Table 2.
Clinical characteristics of P-OPAT patients.
| Characteristics | OPAT (n = 32) | |
|---|---|---|
| Total | % | |
| Diagnosis | ||
| Urinary tract infection | 16 | 50.0 |
| Cellulitis | 4 | 12.5 |
| Osteomyelitis | 4 | 12.5 |
| Native valve endocarditis | 1 | 3.1 |
| Abscess (mandibular and brain) | 2 | 6.3 |
| Fungal infection | 3 | 9.4 |
| Pneumonia | 1 | 3.1 |
| Other infection | 1 | 3.1 |
| Microorganism | ||
| No growth | 19 | 59.4 |
| Escherichia coli | 6 | 18.8 |
| Enterococcus faecalis | 2 | 6.3 |
| Klebsiella pneumonia | 1 | 3.1 |
| K. oxytoca | 1 | 3.1 |
| Staphylococcus aureus | 1 | 3.1 |
| Candida albicans | 1 | 3.1 |
| C. glabrata | 1 | 3.1 |
| Treatment | ||
| Ceftriaxone | 16 | 50.0 |
| Amikacin | 8 | 25.0 |
| Gentamicin | 4 | 12.5 |
| Micafungin | 3 | 9.4 |
| Ganciclovir | 1 | 3.1 |
| Duration of OPAT [median (range)] (days) | 5 (1–27) | |
| Bed days saved | 258 | |
| Intravenous access type | ||
| Central | 0 | 0.0 |
| Peripheral | 32 | 100.0 |